Biotech is a industry of long cycle, high risk and high investment. Thus advanced countries in the world actively invest large amount of money to develop biotech. For example, biomedical R&D cost in US is almost 54 billion dollars each year. In our State 863 Project, there’re also special fund for supporting biotech industry, but it can’t compare with advanced countries. For national investment is limited and civilian capital is hesitated for such investment, biotech development in China is baffled.

Zhong-guan-cun Life Science Park will attract overseas capital through its US office in San Diego, California of US. Thus it can carry out the development and commercialization of projects.

Zhong-guan-cun Life Science Park has the partnership with Beijing Property Right Exchange, and has the exchange seat here，with the capability of stocks transfer system. Thus Zhong-guan-cun Life Science Park can provide effective exit system by reducing financial investment risk.

Zhong-guan-cun Life Science Park has cooperated with Administrative Committee of Zhong-guan-cun Science Park, and set up Zhong-guan-cun Xingye (Beijing) Investment Management Co., Ltd.. This company will implement venture capital and career-developing support for high-tech projects.